Market Data 
Markets
Replies to post #332381 on NorthWest Biotherapeutics Inc (NWBO)
It’s been a very difficult couple of months trying to weigh up the pros and cons of the different types of Dendritic Cell Vaccine treatments on offer, both here and in Germany. We’ve had detailed consultations with Professor Ashkan, at King’s College Hospital; with the Cambridge based bio tech company who manufacture the vaccine; and with IOZK, the German clinic who offer their version of the vaccine.
We’ve come to the conclusion that the UK based offer is the best option for Joel. This is in terms of minimising disruption to his university life as well as there being very promising results from recent clinical trials, in terms of prolonging life. The first stage of the manufacturing process has now started and Joel has a number of appointments with King’s College Hospital London starting in early December for the second stage of manufacturing.
This is all rather scary given that we haven’t raised all of the funds needed. But time is of the essence, whilst Joel is currently stable. So, we therefore need a further BIG push on the fundraising to be able to complete Joel’s treatment.
Thanks again for all of your support and please continue to help us to HelpJoelLiveLonger.
AI
